第11章 付録：略語

図表

※ このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Product Code: BIO099B

The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

REPORT SCOPE

SCOPE OF THE REPORT

The scope of this report includes the single-use technologies used in the bioprocessing industry. These are single-use bioreactors, membrane adsorbers, media bags, tubing and connectors, bioprocess containers, disposable mixing systems, samplers, filter cartridges, depth filtration system, tangential flow filtration system and other single-use products such as valves, clamps, etc.

The report covers market application areas such as monoclonal antibodies (mAbs), vaccines, gene therapy, recombinant proteins, blood derivatives and anti-cancer drugs, and the market by end users, which include contract manufacturing organizations and biopharmaceutical manufacturers. Excluded from this report are control software and the custom-designed software used with single-use biopharmaceutical manufacturing technologies.

Key restraints include leachables and extractables, cost constraints and breakage of bags. The report includes relevant patent analysis and comprehensive profiles of companies that lead the single-use technology market, such as EMD Millipore, GE Healthcare, Pall Corp., Sartorius Stedim Biotech and Thermo Fisher Scientific, among others.

ANALYSTS' CREDENTIALS

A team of professionals in the biotechnology industry has carried out the study. The project manager is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has over 14 years of industry experience. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.